API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
69
PharmaCompass offers a list of Efavirenz API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Efavirenz manufacturer or Efavirenz supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Efavirenz manufacturer or Efavirenz supplier.
PharmaCompass also assists you with knowing the Efavirenz API Price utilized in the formulation of products. Efavirenz API Price is not always fixed or binding as the Efavirenz Price is obtained through a variety of data sources. The Efavirenz Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE, including repackagers and relabelers. The FDA regulates EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE supplier is an individual or a company that provides EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE active pharmaceutical ingredient (API) or EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE finished formulations upon request. The EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE suppliers may include EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE API manufacturers, exporters, distributors and traders.
click here to find a list of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE DMF (Drug Master File) is a document detailing the whole manufacturing process of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE active pharmaceutical ingredient (API) in detail. Different forms of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE DMFs exist exist since differing nations have different regulations, such as EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE DMF submitted to regulatory agencies in the US is known as a USDMF. EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE USDMF includes data on EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE Drug Master File in Korea (EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE. The MFDS reviews the EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE KDMF as part of the drug registration process and uses the information provided in the EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE KDMF to evaluate the safety and efficacy of the drug.
After submitting a EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE suppliers with KDMF on PharmaCompass.
A EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE written confirmation (EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE WC) is an official document issued by a regulatory agency to a EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE manufacturer, verifying that the manufacturing facility of a EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE APIs or EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE finished pharmaceutical products to another nation, regulatory agencies frequently require a EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE WC (written confirmation) as part of the regulatory process.
click here to find a list of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE suppliers with NDC on PharmaCompass.
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE GMP manufacturer or EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE GMP API supplier for your needs.
A EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE CoA (Certificate of Analysis) is a formal document that attests to EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE's compliance with EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE specifications and serves as a tool for batch-level quality control.
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE CoA mostly includes findings from lab analyses of a specific batch. For each EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE may be tested according to a variety of international standards, such as European Pharmacopoeia (EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE EP), EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE USP).